Data from MUSE & TULIP trials of #anifrolumab in #SLE show increased risk of #herpeszoster when compared to placebo. Most HZ events mild-moderate, cutaneous and resolved without discontinuation of drug.
#RheumTwitter #lupus
Abs#0849 #ACR20 @RheumNow
https://t.co/8a6OcZmOso
Links:
Herpes Zoster Events with Anifrolumab in Patients with Active SLE: An Integrate…
https://acrabstracts.org/abstract/herpes-zoster-events-with-anifrolumab-in-pati…
07-11-2020